11-beta-HSD1 inhibitors (Laboratorios SALVAT)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Name11-beta-HSD1 inhibitors (Laboratorios SALVAT)
Drug Alias Name11-beta-hydroxysteroid dehydrogenase inhibitors (Laboratorios SALVAT)SVT-GL-88SVT-GL-63
ClassificationSmall molecules
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Salvat Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratorios Salvat Sa
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A